Top 5 facial rejuvenation stories of the week

Here is a sampling of recent news making waves in facial rejuvenation.

In addition, business news included a new Bloomage/Medytox venture in China.

Bloomage , Medytox create joint venture to develop toxin in China

Bloomage Biotechnology Corporation Limited announced its partnership with the South Korea biotech company Medytox Inc. to establish a joint venture, Medybloom which will develop and promote botulinum toxin type A business in China. Read more

Lip enhancing hyaluronic acid gel effective up to 9 months

Lip enhancement with hyaluronic acid–based gel was well-tolerated and associated with high satisfaction rates for natural-appearing lips lasting for 9 months, according to recent study results. Read more

Researchers warn of rare risk for delayed nodules after Juvéderm Voluma injections

Although uncommon, researchers recommend physicians are aware of the risk for delayed nodules in patients after 3-D facial injections with Juvéderm Voluma, and have a management protocol in place, according to recent study results. Read more

Juvedérm Voluma effects in facial augmentation lasted up to 1 year

Juvedérm Voluma for facial revolumization produced results lasting up to a year in patients with little risk of adverse events, according to recently published study results. Read more

Lower eyelid length increases with age

Researchers created a baseline for lower eyelid measurements which can be helpful in restoring a more youthful lid, as part of a comprehensive approach to managing the aging eye. Read more